# Next Action Recommendation

## Biomni's assessment

### Whether Phase 2 appears complete from the execution perspective

**Phase 2 appears complete.**

All 13 planned execution steps were performed. All 11 acceptance checks passed:

1. CSVs load cleanly (structure_inventory 37×35, residue_mapping 185×13, ligand_inventory 9×21)
2. 37 structure_inventory rows
3. 185 residue_mapping rows
4. 37 mmCIF files in `protein_structure_files/`
5. 12 files in `ligand_structure_files/`
6. No excluded alias string in data tables
7. `source_database_url_or_identifier` 100% coverage in structure_inventory
8. Residue coverage 179/185 = 96.8%
9. 10 covalent Cys727 structures correctly identified
10. Phase 1 inhibitor mapping correct (HRO761 in 8PFO+9S18, VVD-214 in 7GQU)
11. All 5 markdown documentation files exist

No docking, no MD, no mutant models, and no binding-affinity claims were produced, consistent with the project directive.

### Whether ChatGPT should approve, repair, or reject Phase 2

**Recommendation: approve, with optional repairs if review surfaces issues.**

The Phase 2 inventory is internally consistent, every claim is traceable to a specific RCSB REST API response or coordinate-level parse, and the boundary conditions were respected. The 14 open questions in `OPEN_QUESTIONS_FOR_CHATGPT.md` are scientific scope decisions (template selection, mutation subset, inhibitor handling) rather than data-quality defects.

Known data-quality flags that ChatGPT should weigh:

- **9OG8 covalent bond distance (1.428 Å)** is anomalously short. This is documented in `phase2_missing_data_report.md` §3. ChatGPT should decide whether to exclude 9OG8 from Phase 3 or require visual inspection before use.
- **3 of 6 Phase 1 inhibitors** (SNV5686, J&J Compound A/B/C, AbbVie DEL series) could not be linked to public chemical identifiers. This is a public-data limitation, not an execution error.
- **L528 is missing in 6 of 37 structures** due to polymer construct design (not poor density). This constrains L528S modeling to the 31 structures where L528 is present.

If ChatGPT identifies additional issues during review, repairs can be requested before Phase 3 authorization.

### Recommended next step after ChatGPT review

1. ChatGPT reviews the 14 open questions in `OPEN_QUESTIONS_FOR_CHATGPT.md` and records the verdict in `CHATGPT_REVIEW.md`.
2. If ChatGPT approves: the user verifies the Phase 2 outputs using `phase2_user_verification_checklist.md`.
3. If ChatGPT requests repairs: Biomni performs the repairs, re-runs acceptance checks, and re-submits for review.
4. After both ChatGPT and the user approve: Phase 3 scope is defined (which mutations, which templates) based on ChatGPT's answers to open questions 11 and 12.
5. Only then is Phase 3 authorized to begin.

### What should NOT happen yet

- **Phase 3 mutant model generation** — not authorized until ChatGPT and user verify Phase 2.
- **Docking** — planned for Phase 5, not Phase 3.
- **Molecular dynamics** — remains on hold per project directive.
- **Virtual screening** — not part of this project's scope.
- **Binding-affinity claims** — not to be made at any phase without experimental grounding.
- **Modification of Phase 1 or Phase 2 science files** — unless ChatGPT explicitly requests a repair.

## Explicit stop statement

Phase 3 should only begin after ChatGPT and user verification.
